Now that LymPro is ready to commercialize with the RUO market I think Gerald would be foolish to accept a partnership deal before any sales have come in. Why would he do that? In the next few months we are going to get more and more pharmas signing up to use Lympro as their screening diagnostic in the AD trials to save money and improve accuracy! LymPro's value is only going to go up in the next few months!

Gerald's quote to me back in Las Vegas over a year ago is even more applicable today: "People will pay you x today, but will pay 100x a little down the road."

I know I have been repeating this a lot lately, but I think news of Lympro sales will be the main catalyst to lift the stock price!! Even revenue isn't the critical thing in the next few months because if they are getting a few pharmas to commit to LymPro each month, the revenue will soon follow. And once that happens, someone will pay us "100x" for LymPro!

The LymPro Launch is what we should be keeping our eyes on. The series E thing may mean no partnership up front money is near.....but that won't keep us from getting above .20 cents in January or February based on the other news we'll be getting on Lympro and Retintis.